EE9800197A - Pidevalt toimeainena diltiaseemi vabastavad mikrograanulid - Google Patents

Pidevalt toimeainena diltiaseemi vabastavad mikrograanulid

Info

Publication number
EE9800197A
EE9800197A EE9800197A EE9800197A EE9800197A EE 9800197 A EE9800197 A EE 9800197A EE 9800197 A EE9800197 A EE 9800197A EE 9800197 A EE9800197 A EE 9800197A EE 9800197 A EE9800197 A EE 9800197A
Authority
EE
Estonia
Prior art keywords
diltiazem
sustained release
release microgranule
microgranule
sustained
Prior art date
Application number
EE9800197A
Other languages
English (en)
Other versions
EE04045B1 (et
Inventor
Debregeas Patrice
Leduc G�rard
Oury Pascal
Suplie Pascal
Original Assignee
Laboratoires Des Produits Ethiques Ethypharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9485856&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EE9800197(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Laboratoires Des Produits Ethiques Ethypharm filed Critical Laboratoires Des Produits Ethiques Ethypharm
Publication of EE9800197A publication Critical patent/EE9800197A/et
Publication of EE04045B1 publication Critical patent/EE04045B1/et

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
EE9800197A 1995-12-22 1996-12-23 Pidevalt toimeainena diltiaseemi vabastavad mikrograanulid EE04045B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9515361A FR2742660B1 (fr) 1995-12-22 1995-12-22 Nouvelles formes de microgranules a liberation prolongee contenant du diltiazem comme principe actif
PCT/FR1996/002040 WO1997023219A1 (fr) 1995-12-22 1996-12-23 Microgranules a liberation prolongee contenant du diltiazem comme principe actif

Publications (2)

Publication Number Publication Date
EE9800197A true EE9800197A (et) 1998-12-15
EE04045B1 EE04045B1 (et) 2003-06-16

Family

ID=9485856

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9800197A EE04045B1 (et) 1995-12-22 1996-12-23 Pidevalt toimeainena diltiaseemi vabastavad mikrograanulid

Country Status (27)

Country Link
US (3) US6228395B1 (et)
EP (1) EP0868184B1 (et)
JP (1) JP2000506500A (et)
KR (1) KR100354054B1 (et)
CN (1) CN1145488C (et)
AR (1) AR004410A1 (et)
AT (1) ATE238798T1 (et)
AU (1) AU721949B2 (et)
BG (1) BG63770B1 (et)
BR (1) BR9612225A (et)
CA (1) CA2242224C (et)
DE (1) DE69627880T2 (et)
DK (1) DK0868184T3 (et)
EA (1) EA001721B1 (et)
EE (1) EE04045B1 (et)
ES (1) ES2198505T3 (et)
FR (1) FR2742660B1 (et)
GE (1) GEP20022629B (et)
HK (1) HK1018400A1 (et)
HU (1) HU224214B1 (et)
IL (1) IL125047A (et)
NO (1) NO324680B1 (et)
NZ (1) NZ324739A (et)
PL (1) PL186621B1 (et)
PT (1) PT868184E (et)
WO (1) WO1997023219A1 (et)
ZA (1) ZA9610776B (et)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2742660B1 (fr) * 1995-12-22 1998-04-03 Ethypharm Lab Prod Ethiques Nouvelles formes de microgranules a liberation prolongee contenant du diltiazem comme principe actif
US6162463A (en) * 1997-05-01 2000-12-19 Dov Pharmaceutical Inc Extended release formulation of diltiazem hydrochloride
FR2790668B1 (fr) * 1999-03-12 2002-07-26 D B F Granules contenant une substance vegetale et leur procede de preparation
EP1064937A1 (en) * 1999-06-28 2001-01-03 Sanofi-Synthelabo Timed dual release dosage forms comprising a short acting hypnotic or a salt thereof
EP1064938A1 (en) * 1999-06-28 2001-01-03 Sanofi-Synthelabo Pharmaceutical dosage forms for controlled release producing at least a timed pulse
US7179483B2 (en) 2000-04-26 2007-02-20 Watson Pharmaceuticals, Inc. Compositions and methods for transdermal oxybutynin therapy
FR2831546B1 (fr) * 2001-10-31 2007-03-23 Atofina Materiau polymere thermoplastique pour supports d'enregistrement d'informations audio et/ou optiques
CN1874764B (zh) * 2003-10-10 2012-08-01 埃法尔姆公司 含有银杏提取物的持续释放微粒及其制备方法
EP1698349A4 (en) * 2003-12-25 2009-12-16 Takeda Pharmaceutical PROCESS FOR IMPROVING THE SUITABILITY FOR GRANULATION
JP2005306778A (ja) * 2004-04-21 2005-11-04 Basf Ag 徐放性製剤及びその製造方法
WO2006013431A1 (en) * 2004-07-29 2006-02-09 Pfizer Limited Stable controlled-release pharmaceutical formulation of eletriptan
US8778395B2 (en) * 2005-08-11 2014-07-15 Andrx Labs, Llc Diltiazem controlled release formulation and method of manufacture
US8158156B2 (en) * 2006-06-19 2012-04-17 Alpharma Pharmaceuticals, Llc Abuse-deterrent multi-layer pharmaceutical composition comprising an opioid antagonist and an opioid agonist
ITFI20110172A1 (it) 2011-08-08 2013-02-09 Valpharma Sa Formulazione multiparticolata a rilascio modificato di diltiazem hcl.

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE56999B1 (en) * 1983-12-22 1992-03-11 Elan Corp Plc Pharmaceutical formulation
IT1200217B (it) * 1986-09-30 1989-01-05 Valducci Roberto Membrana per uso farmaceutico ed industriale
DK173505B1 (da) * 1987-02-20 2001-01-15 Pharmatec Internat S R L Fremgangsmåde til fremstilling af en diltiazempellet med langsom afgivelse og anvendelse af således fremstillede pelleter t
JPH07552B2 (ja) * 1987-11-06 1995-01-11 田辺製薬株式会社 持効性製剤
FR2623714B1 (fr) * 1987-11-26 1990-04-20 Ethypharm Sa Forme a liberation prolongee du diltiazem, et son medicament ainsi obtenu
FR2624732B1 (fr) * 1987-12-21 1991-02-15 Synthelabo Formulation pharmaceutique a liberation prolongee
FR2630647B1 (fr) * 1988-04-27 1991-08-16 Sanofi Sa Microbilles de diltiazem, leur procede de fabrication et compositions pharmaceutiques a liberation prolongee les contenant
US5288505A (en) 1991-06-26 1994-02-22 Galephar P.R., Inc., Ltd. Extended release form of diltiazem
US5229135A (en) * 1991-11-22 1993-07-20 Prographarm Laboratories Sustained release diltiazem formulation
US5376384A (en) 1992-12-23 1994-12-27 Kinaform Technology, Inc. Delayed, sustained-release pharmaceutical preparation
US5834024A (en) * 1995-01-05 1998-11-10 Fh Faulding & Co. Limited Controlled absorption diltiazem pharmaceutical formulation
FR2742660B1 (fr) * 1995-12-22 1998-04-03 Ethypharm Lab Prod Ethiques Nouvelles formes de microgranules a liberation prolongee contenant du diltiazem comme principe actif

Also Published As

Publication number Publication date
NO982738L (no) 1998-08-21
EP0868184A1 (fr) 1998-10-07
US6660296B2 (en) 2003-12-09
CN1145488C (zh) 2004-04-14
BG63770B1 (bg) 2002-12-29
US6228395B1 (en) 2001-05-08
AU721949B2 (en) 2000-07-20
AR004410A1 (es) 1998-11-04
AU1198397A (en) 1997-07-17
ZA9610776B (en) 1997-06-30
PL327567A1 (en) 1998-12-21
IL125047A (en) 2003-05-29
KR19990076717A (ko) 1999-10-15
EA199800593A1 (ru) 1998-12-24
BR9612225A (pt) 1999-07-13
DE69627880D1 (de) 2003-06-05
JP2000506500A (ja) 2000-05-30
DK0868184T3 (da) 2003-08-25
HU224214B1 (hu) 2005-06-28
PL186621B1 (pl) 2004-02-27
CA2242224C (fr) 2004-01-13
IL125047A0 (en) 1999-01-26
PT868184E (pt) 2003-09-30
EA001721B1 (ru) 2001-08-27
CA2242224A1 (fr) 1997-07-03
US20020182253A1 (en) 2002-12-05
ATE238798T1 (de) 2003-05-15
HUP9904129A3 (en) 2000-11-28
NZ324739A (en) 2000-01-28
DE69627880T2 (de) 2004-03-11
HUP9904129A2 (hu) 2000-04-28
CN1207681A (zh) 1999-02-10
HK1018400A1 (en) 1999-12-24
FR2742660A1 (fr) 1997-06-27
NO324680B1 (no) 2007-12-03
NO982738D0 (no) 1998-06-12
BG102555A (en) 1999-02-26
EE04045B1 (et) 2003-06-16
FR2742660B1 (fr) 1998-04-03
ES2198505T3 (es) 2004-02-01
US6383516B1 (en) 2002-05-07
KR100354054B1 (ko) 2003-02-14
WO1997023219A1 (fr) 1997-07-03
EP0868184B1 (fr) 2003-05-02
GEP20022629B (en) 2002-02-25

Similar Documents

Publication Publication Date Title
IS1998B (is) 4'' -setnar - 9 - deoxó - 9 - aza - 9a - hómóerýþrómýsín A afleiður
DE69624884T2 (de) Wabenkörper
FR2734097B1 (fr) Laser a semiconducteurs
DE59604607D1 (de) Gelenkloses prothesenfussteil
ATE222213T1 (de) Anbauaufzug
DE69532628D1 (de) Fixiersteuervorrichtung
EE9800197A (et) Pidevalt toimeainena diltiaseemi vabastavad mikrograanulid
DE69633886D1 (de) Spannung-Strom-Umsetzer
FR2738029B1 (fr) Loquet souple a traction
NO980373L (no) A/D omformingsapparat
DE59608223D1 (de) Konverter
DE29603331U1 (de) Bewegungsumsetzer
FI950335A (fi) Hätäkutsulaite
DE29511581U1 (de) Extrakoronales Geschiebe
DE29510703U1 (de) Hebezeug
KR970003380U (ko) 전주 보호구
DE29513778U1 (de) Öse
KR970038681U (ko) 화물 자동차의 사이드 스텝 구조
KR970001627U (ko) 구명용 에어백
KR970041632U (ko) 자동차의 자동 시동 장치
FI950432A0 (fi) En frikolvsmotor med lineaer positions-givare
ITPD940025A0 (it) Benna a mordente vibrante
KR970037555U (ko) 자동차의 사이드 멤버
KR970022996U (ko) 자동차의 사이드 멤버
KR970022995U (ko) 자동차의 사이드 멤버

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20031231

KB4A Valid patent at the end of a year

Effective date: 20041231

KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20091231

KB4A Valid patent at the end of a year

Effective date: 20101231